Study Stopped
The study design was not compatible with recruiting patients to the investigation
The Antidepressant Efficacy of Low Frequency rTMS as add-on
The Antidepressive Effect of Low Frequency Right Prefrontal Repetitive Transcranial Magnetic Stimulation as add-on to Antidepressant Drug Treatment. A Blinded, Placebo Controlled Randomised Study.
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
rTMS has appeared a potential new non-invasive antidepressant method, which implies non-convulsive focal stimulation of the brain through a time varying magnetic field. ). Research on rTMS reports of minimal side effects of the method . The majority of clinically controlled studies have used high frequency stimulation of the left frontal cortex . Fewer studies have used right prefrontal, which has less side effects, such as local discomfort and a lower risk of releasing epileptic seizures, than high frequency stimulation .Both stimulus models has been shown to have statistically significant antidepressant effect and recent research clearly indicates that low frequency rTMS of the right prefrontal cortex i associated with an antidepressant effect at the same level as the high frequency model. Therefore the investigators want to examine the antidepressant effect of a specific rTMS low frequency model in a clinical setting using a placebo controlled, randomized double blind design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Dec 2016
Shorter than P25 for not_applicable depression
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 15, 2016
CompletedFirst Posted
Study publicly available on registry
November 17, 2016
CompletedStudy Start
First participant enrolled
December 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedNovember 29, 2017
November 1, 2016
6 months
November 15, 2016
November 28, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
remission
the number of patients obtaining a Hamilton-17 item total score of \< 8
8 weeks
Secondary Outcomes (2)
Response
8 weeks
Cognitive function
8 weeks
Study Arms (2)
Right prefrontal low frequency rTMS.
ACTIVE COMPARATORRight prefrontal low frequency rTMS (1Hz). A treatment session each day in four weeks apart from weekends. Each session is administered with 2 pulse trains of 180 sec with a 2 min interval
Sham-rTMS
PLACEBO COMPARATORRight prefrontal rTMS sham treatment. A treatment session each day in four weeks apart from weekends. Each session is administered with 2 pulse trains of 180 sec with a 2 min interval
Interventions
A treatment session each day in four weeks apart from weekends. Each session is administered with 2 pulse trains of 180 sec with a 2 min interval
Right prefrontal rTMS sham treatment. A treatment session each day in four weeks apart from weekends. Each session is administered with 2 pulse trains of 180 sec with a 2 min interval
Eligibility Criteria
You may qualify if:
- Out-patients referred to Aarhus University Hospital, Risskov
- Moderate-severe uni- and bipolar depression according to ICD-10
- Age 18-80 years
You may not qualify if:
- Organic brain disease.
- Epileptic seizure \< 2 years
- Patients with implanted metal parts in the brain or chest
- Patients with pacemaker
- Medical diseases with cerebral impact
- Serious suicidal danger
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Poul Erik Buchholtz, MD
Aarhus University Hospital, Risskov
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 15, 2016
First Posted
November 17, 2016
Study Start
December 1, 2016
Primary Completion
June 1, 2017
Study Completion
December 1, 2017
Last Updated
November 29, 2017
Record last verified: 2016-11
Data Sharing
- IPD Sharing
- Will not share